---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-005757"
form_type: "8-K"
ticker: "PPCB"
cik: "0001517681"
company_name: "Propanc Biopharma, Inc."
filed_at: "2023-02-22T23:59:59+00:00"
generated_at: "2026-06-19T04:44:31.813607+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Propanc Biopharma retires final convertible note via full conversion to common stock

## Summary
- Retired final convertible promissory note dated June 30, 2022, with 1800 Diagonal Lending LLC.
- Full payment made on Feb 15, 2023, converting all outstanding principal and interest into common stock.
- Zero balance remaining; no further obligations to issue securities to the holder.
- No specific financial impact or conversion terms disclosed in the filing.

## SEC filing metadata
- accession: 0001493152-23-005757
- form_type: 8-K
- ticker: PPCB
- cik: 0001517681
- company_name: Propanc Biopharma, Inc.
- filed_at: 2023-02-22T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517681/000149315223005757/0001493152-23-005757-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517681/000149315223005757/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-005757
- JSON: https://secwatch.observer/filing/0001493152-23-005757.json
- Plain text: https://secwatch.observer/filing/0001493152-23-005757.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.